| Causes and significance of markedly elevated serum ferritin levels in an academic medical center C Moore Jr, M Ormseth, H Fuchs JCR: Journal of Clinical Rheumatology 19 (6), 324-328, 2013 | 154 | 2013 |
| The non-coding RNA interactome in joint health and disease SA Ali, MJ Peffers, MJ Ormseth, I Jurisica, M Kapoor Nature Reviews Rheumatology 17 (11), 692-705, 2021 | 140 | 2021 |
| Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis MJ Ormseth, CP Chung, AM Oeser, MA Connelly, T Sokka, P Raggi, ... Arthritis research & therapy 17, 1-8, 2015 | 80 | 2015 |
| Heart failure risk associated with rheumatoid arthritis–related chronic inflammation MJ Ahlers, BD Lowery, E Farber‐Eger, TJ Wang, W Bradham, MJ Ormseth, ... Journal of the American Heart Association 9 (10), e014661, 2020 | 70 | 2020 |
| Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis MJ Ormseth, A Lipson, N Alexopoulos, GR Hartlage, AM Oeser, A Bian, ... Arthritis care & research 65 (9), 1410-1415, 2013 | 61 | 2013 |
| Utility of select plasma microRNA for disease and cardiovascular risk assessment in patients with rheumatoid arthritis MJ Ormseth, JF Solus, KC Vickers, AM Oeser, P Raggi, CM Stein The Journal of rheumatology 42 (10), 1746-1751, 2015 | 58 | 2015 |
| Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus MJ Ormseth, LL Swift, S Fazio, MF Linton, P Raggi, JF Solus, A Oeser, ... Lupus 22 (1), 26-33, 2013 | 58 | 2013 |
| Duloxetine in the management of diabetic peripheral neuropathic pain MJ Ormseth, BA Scholz, CS Boomershine Patient preference and adherence, 343-356, 2011 | 58 | 2011 |
| GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus CP Chung, MJ Ormseth, MA Connelly, A Oeser, JF Solus, JD Otvos, ... Lupus 25 (3), 296-300, 2016 | 53 | 2016 |
| Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial MJ Ormseth, AM Oeser, A Cunningham, A Bian, A Shintani, J Solus, ... Arthritis research & therapy 15, 1-9, 2013 | 52 | 2013 |
| Effect of drug therapy on net cholesterol efflux capacity of high‐density lipoprotein–enriched serum in rheumatoid arthritis MJ Ormseth, PG Yancey, JF Solus, SL Bridges Jr, JR Curtis, MRF Linton, ... Arthritis & rheumatology 68 (9), 2099-2105, 2016 | 46 | 2016 |
| Loss of macrophage low-density lipoprotein receptor–related protein 1 confers resistance to the antiatherogenic effects of tumor necrosis factor-α inhibition L Zhu, I Giunzioni, H Tavori, R Covarrubias, L Ding, Y Zhang, M Ormseth, ... Arteriosclerosis, thrombosis, and vascular biology 36 (8), 1483-1495, 2016 | 43 | 2016 |
| Milnacipran for the management of fibromyalgia syndrome MJ Ormseth, AE Eyler, CL Hammonds, CS Boomershine Journal of pain research, 15-24, 2010 | 41 | 2010 |
| Development and validation of a MicroRNA panel to differentiate between patients with rheumatoid arthritis or systemic lupus erythematosus and controls MJ Ormseth, JF Solus, Q Sheng, F Ye, Q Wu, Y Guo, AM Oeser, RM Allen, ... The Journal of rheumatology 47 (2), 188-196, 2020 | 40 | 2020 |
| High-density lipoprotein function in rheumatoid arthritis MJ Ormseth, CM Stein Current opinion in lipidology 27 (1), 67-75, 2016 | 39 | 2016 |
| Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator WS Bradham, MJ Ormseth, A Oeser, JF Solus, T Gebretsadik, A Shintani, ... Inflammation 37, 801-808, 2014 | 36 | 2014 |
| Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis MJ Ormseth, LL Swift, S Fazio, MRF Linton, CP Chung, P Raggi, YH Rho, ... Atherosclerosis 219 (2), 869-874, 2011 | 35 | 2011 |
| Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus K Voss, AE Sewell, ES Krystofiak, KN Gibson-Corley, AC Young, ... Science immunology 8 (79), eabq0178, 2023 | 34 | 2023 |
| Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis MJ Ormseth, JF Solus, Q Sheng, SC Chen, F Ye, Q Wu, AM Oeser, ... Clinical rheumatology 40, 2211-2219, 2021 | 27 | 2021 |
| Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator–activated receptor γ agonist therapy MJ Ormseth, AM Oeser, A Cunningham, A Bian, A Shintani, J Solus, ... Arthritis & Rheumatology 66 (9), 2331-2338, 2014 | 26 | 2014 |
